Toxicity of dose-escalated, hypofractionated helical tomotherapy for inoperable thoracic esophageal squamous cell carcinoma

doi:10.5306/wjco.v16.i5.101378

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (819)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

HTML

224

Figures (1-2)

124

Tables (1-3)

119

Sum=478

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

145

Sum=237

Publishing Process of This Article

Item

Count

Browse

Download

Sum=83

May 24, 2025 (publication date) through Jun 13, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. May 24, 2025; 16(5): 101378
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.101378

Table 3 Ordinal logistic regression of esophageal toxicity

	Estimate	SE	Wald	P value	95% confidence interval
Dose level (Gy per fraction)	-0.96	1.14	0.70	0.40	-3.20, 1.28
EQD₂ (α/β = 10)	0.17	0.06	6.99	0.01	0.04, 0.29
Tumor classification	-0.12	0.37	0.11	0.74	-0.86, 0.61

EQD₂: Equivalent dose at 2Gy per fraction.

Citation: Zhang SM, Sun J, Pan XO, Zhu WC, Zhou YK. Toxicity of dose-escalated, hypofractionated helical tomotherapy for inoperable thoracic esophageal squamous cell carcinoma. World J Clin Oncol 2025; 16(5): 101378
URL: https://www.wjgnet.com/2218-4333/full/v16/i5/101378.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i5.101378